Pediatric highly active antiretroviral therapy in Mozambique: An integrated model of care

Minerva Pediatrica

Volumn 58, Issue 5, 2006, Pages 483-490

  Marazzi, M C ^a   Germano, P ^b   Liotta, G ^c   Buonomo, E ^c   Guidotti, G ^d   Palombi, L ^c  

^a LUMSA UNIVERSITY   (Italy)

^b DREAM Program   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antiretroviral therapy, highly active; Clid; HIV; Public Health

Indexed keywords

ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; LAMIVUDINE; NEVIRAPINE; RIFAMPICIN; ZIDOVUDINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOZAMBIQUE; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; NUTRITIONAL SUPPORT; PATIENT EDUCATION; TUBERCULOSIS; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MOZAMBIQUE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES;

EID: 33750607878     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236-43.
2. Sharland M, Blanche S, Castelli G, Ramos J and Gibb DM (PENTA Steering Committee). PENTA Guidelines for the use of Antiretroviral therapy, 2004. HIV Medicine 2004;5 Suppl 2:61-86.
3. Working Group on Antiretroviral Therapy and medical Management of HIV-infected Children. Guidelines for the use of Antiretroviral Agents in pediatric HIV Infection.
4. Ndekha MJ, Manary MJ, Ashorn P, Briend A. Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV infected Malawian children. Acta Paediatr 2005;94:222-5.
5. Arpadi SM, Cuff Pa, Kotler DP, Wang J, Bamji M, Lange M et al. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children. J Nutr 2000;130:2498-502.
6. Newell ML, Borja MC, Peckham C, European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics 2003;111:e52-60.
7. Adjuik M, Smith T, Clark S, Todd J, Garrib A, Kinfu Y et al. Cause specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ 2006;84:181-8.
8. WHO - Regional Office for South-East Asia. Tuberculosis Factsheet. http://w3.whosea.org/en/Section10/section2097/section2106_10681.htm.
9. WHO-Child and Adolescent Health and Development. Overview of CHA. http://www.who.int/child-adolescent-health/OVERVIEW/CHILD_HEALTH/ child_epidemiology.htm.
10. Rowe KA, Steketee RW, Rowe SY, Snow RW, Korenromp EL, Stein B et al. Estimates of the burden of mortality directly attributable to malaria for children under 5 years of age in Africa for the year 2000. http://www.who.int/ child-adolescent-health/New_Publications/CHILD_HEALTH/EPI/ CHERG_Malaria_Mortality.pdf
11. Carneiro I, Roca-Feltrer A, Schellenberg J. Estimates of the burden of malaria morbidity in Africa in children under the age of five years. http://www.who.int/child-adolescent-health/New_Publications/CHILD_HEALTH/EPI/ CHERG_Malaria_Morbidity.pdf
12. Marazzi MC, Guidotti G, Liotta G, Palombi L. DREAM: an integrated faith-based initiative to treat HIV/AIDS in Mozambique: case study. Geneva: WHO; 2005.
13. WHO - NCHS/WHO international reference data for the weight and Height of children. http://www.who.int/nutgrowthdb/reference/en/
14. Nachman SA, Lindsey JC, Move J, Stanley KE, Johnson GM, Krogstadt PA et al. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J 2005;24:352-7.
15. Verweel G, van Rossum AM, Hartwig NG, Wolfs Tf, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002;109:E25.
16. Brogly S, Williams P, Seage Gr 3rd, Oleske JM, Van Dyke R, McIntosh K. Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trial to practice. JAMA 2005;293:2272-4.
17. Gonzalez Tome MI, Ramos Amador JT, Sanchez Granados JM, Guillen S, Rojo P, Ruiz Contreras J. Effectiveness of antiretroviral therapy in HIV-1 infected children. A cross-sectional study. An Pediatr (Barc) 2005;62:32-7.
18. Fassinou P, Elenga N, Rouet F, Laguide R, Kouakoussui KA, Timite M et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS 2004;18:1905-13.
19. Kouakoussi A, Fassinou P, Anaky MF, Elenga N, Laguide R, Wemin ML et al. Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast. Paediatr Respir Rev 2004;5:311-5.
20. Taha TE, Kumwenda NI, Hoover DR, Biggar RJ, Broadhead RL, Cassol S et al. Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African Children over on year of age. AIDS 2000;14:453-9.
21. Elev B, Nuttall J, Davies MA, Smith L, Cowburn C, Buys H et al. Initial experience of a public health sector antiretoriviral treatment programme for HIV-infected children and their infected parents. S Afr Med J 2004;94:643-6.
22. Rouet F, Sakarovitch C, Msellati P, Elenga N, Montcho C, Viho I et al. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection and disease progression in African HIV-1 infected children. Pediatrics 2003;112:e289-97.
23. WHO. Scaling up antiretroviral treatment in resource-limited settings: treatment guidelines for a public health approach. 2003 revision http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf accessed on 13/03/2006.